unknown
Stage
1
Investors
About
Horizon Discovery drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine. With more than a decade of experience in the engineering of cell lines, Horizon offers innovative tools and services based upon the ability t
Explore Horizon Discovery's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.